Nuo Therapeutics, Inc. SEC filings AURX
Nuo Therapeutics, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jun 8, 2005. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 6, 2026 (material agreement, new debt, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 6, 2026 | Oct 6, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Oct 6, 2026 | Sep 30, 2026 |
| 4/A | Form 4/a | Aug 31, 2026 | Aug 27, 2026 |
| 4 | Insider transaction | Aug 28, 2026 | Aug 27, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 17, 2026 | Aug 17, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 5, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 3, 2026 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 3, 2026 | May 29, 2026 |
| 4 | Insider transaction | Jun 2, 2026 | May 29, 2026 |
| 4/A | Form 4/a | Jun 2, 2026 | Jan 23, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2026 | — |
| 4 | Insider transaction | Jan 26, 2026 | Jan 23, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jan 26, 2026 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jan 26, 2026 | Jan 21, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 1, 2026 |
| 4 | Insider transaction | Dec 22, 2025 | Dec 17, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Dec 17, 2025 | Dec 16, 2025 |
| 4/A | Form 4/a | Dec 11, 2025 | Dec 9, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| 4 | Insider transaction | Dec 3, 2025 | Nov 28, 2025 |
| 10-Q | Quarterly report | Oct 30, 2025 | Sep 30, 2025 |
| DEFA14A | Additional proxy material | Oct 30, 2025 | — |
| DEF 14A | Proxy statement | Oct 30, 2025 | Dec 16, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Oct 10, 2025 | Oct 7, 2025 |
| D | Filing | Aug 4, 2025 | — |
| 4/A | Form 4/a | Aug 4, 2025 | Aug 1, 2025 |
| 4 | Insider transaction | Aug 4, 2025 | Aug 1, 2025 |
| 4 | Insider transaction | Aug 4, 2025 | Aug 1, 2025 |
| 4 | Insider transaction | Aug 4, 2025 | Aug 1, 2025 |
| 4 | Insider transaction | Aug 4, 2025 | Jul 31, 2025 |
| 4 | Insider transaction | Aug 1, 2025 | Jul 30, 2025 |
| 4 | Insider transaction | Aug 1, 2025 | Jul 30, 2025 |
| 10-Q | Quarterly report | Jul 31, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement
|
May 15, 2025 | May 14, 2025 |
| EFFECT | Filing | May 12, 2025 | — |
| S-3/A | Form s-3/a | May 9, 2025 | — |
| CORRESP | Letter to the SEC | May 8, 2025 | — |
| UPLOAD | Letter from the SEC | May 6, 2025 | — |
| S-3 | Shelf registration | May 1, 2025 | — |
| 10-Q | Quarterly report | Apr 30, 2025 | Mar 31, 2025 |
| S-8 | Employee stock plan registration | Apr 10, 2025 | — |
| 10-K | Annual report | Apr 1, 2025 | Dec 31, 2024 |
| NT 10-K | Form nt 10-k | Apr 1, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Nov 19, 2024 | Nov 15, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 22, 2024 | — |
| D | Filing | Sep 23, 2024 | — |
| 4 | Insider transaction | Sep 19, 2024 | Sep 19, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 19, 2024 | Sep 18, 2024 |
| 10-Q | Quarterly report | Aug 12, 2024 | Jun 30, 2024 |
| 4 | Insider transaction | Jul 22, 2024 | Jul 17, 2024 |
| 4 | Insider transaction | Jul 22, 2024 | Jul 17, 2024 |
| 4 | Insider transaction | Jul 22, 2024 | Jul 17, 2024 |
| 8-K |
Current report
Other events
|
Jun 27, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Auditor change
|
Jun 11, 2024 | Jun 7, 2024 |
| D | Filing | May 22, 2024 | — |
| 4 | Insider transaction | May 21, 2024 | May 20, 2024 |
| 4 | Insider transaction | May 21, 2024 | May 20, 2024 |
| 4 | Insider transaction | May 21, 2024 | May 20, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 21, 2024 | May 17, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 10-K | Annual report | Apr 19, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 16, 2024 | Apr 16, 2024 |
| NT 10-K | Form nt 10-k | Apr 1, 2024 | Dec 31, 2023 |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 12, 2024 | — |
| D | Filing | Dec 22, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Dec 20, 2023 | — |
| 4 | Insider transaction | Dec 20, 2023 | Dec 19, 2023 |
| 4 | Insider transaction | Dec 20, 2023 | Dec 19, 2023 |
| 4 | Insider transaction | Dec 20, 2023 | Dec 19, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 20, 2023 | Dec 18, 2023 |
| 10-Q | Quarterly report | Nov 20, 2023 | Sep 30, 2023 |
| NT 10-Q | Form nt 10-q | Nov 15, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| D | Filing | Aug 8, 2023 | — |
| 4 | Insider transaction | Aug 4, 2023 | Aug 1, 2023 |
| 4 | Insider transaction | Aug 3, 2023 | Aug 1, 2023 |
| 4 | Insider transaction | Aug 3, 2023 | Aug 1, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 3, 2023 | Aug 1, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 10-K/A | Amended annual report | Apr 18, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Apr 17, 2023 | Dec 31, 2022 |
| NT 10-K | Form nt 10-k | Mar 31, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Dec 5, 2022 | Dec 2, 2022 |
| 4 | Insider transaction | Nov 14, 2022 | Nov 9, 2022 |
| 10-Q | Quarterly report | Nov 4, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Nov 4, 2022 | Sep 30, 2021 |
| DEFA14A | Additional proxy material | Oct 20, 2022 | — |
| DEF 14A | Proxy statement | Oct 20, 2022 | Dec 2, 2022 |
| 3/A | Form 3/a | Oct 18, 2022 | Jan 1, 2022 |
| 8-K |
Current report
Other events
|
Sep 30, 2022 | Sep 29, 2022 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 30, 2022 | Aug 24, 2022 |
| 10-Q/A | Amended quarterly report | Aug 10, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | Aug 8, 2022 | Jun 30, 2022 |
| SC 13D/A | Amended ownership over 5% (active) | Jul 5, 2022 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jul 5, 2022 | — |
| SC 13D | Ownership over 5% (active) | Jul 5, 2022 | — |
| 8-K |
Current report
Other events
|
Jun 28, 2022 | Jun 23, 2022 |
| 4 | Insider transaction | Jun 15, 2022 | Jun 6, 2022 |
| D | Filing | May 19, 2022 | — |
| 10-Q | Quarterly report | May 16, 2022 | Mar 31, 2022 |
| D | Filing | May 6, 2022 | — |
| 4 | Insider transaction | May 2, 2022 | Apr 29, 2022 |
| 4 | Insider transaction | May 2, 2022 | Apr 29, 2022 |
| 4 | Insider transaction | May 2, 2022 | Apr 29, 2022 |
| 4 | Insider transaction | May 2, 2022 | Apr 29, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 2, 2022 | Apr 29, 2022 |
| DEF 14C | Information statement | Apr 27, 2022 | Apr 27, 2022 |
| 3 | Initial insider ownership | Apr 26, 2022 | Jan 1, 2022 |
| 4 | Insider transaction | Apr 26, 2022 | Mar 4, 2022 |
| 4 | Insider transaction | Apr 26, 2022 | Mar 4, 2022 |
| 4 | Insider transaction | Apr 26, 2022 | Mar 4, 2022 |
| 4 | Insider transaction | Apr 26, 2022 | Mar 4, 2022 |
| 4 | Insider transaction | Apr 26, 2022 | Mar 4, 2022 |
| 5 | Annual insider ownership | Apr 26, 2022 | Dec 31, 2021 |
| 5 | Annual insider ownership | Apr 26, 2022 | Dec 31, 2021 |
| 5 | Annual insider ownership | Apr 26, 2022 | Dec 31, 2021 |
| 5 | Annual insider ownership | Apr 26, 2022 | Dec 31, 2020 |
| 5 | Annual insider ownership | Apr 26, 2022 | Dec 31, 2020 |
| 5 | Annual insider ownership | Apr 26, 2022 | Dec 31, 2020 |
| 5 | Annual insider ownership | Apr 26, 2022 | Dec 31, 2019 |
| 5 | Annual insider ownership | Apr 26, 2022 | Dec 31, 2019 |
| 5 | Annual insider ownership | Apr 26, 2022 | Dec 31, 2019 |
| 10-K | Annual report | Apr 15, 2022 | Dec 31, 2021 |
| NT 10-K | Form nt 10-k | Mar 31, 2022 | Dec 31, 2021 |
| SC TO-T/A | Final amendment | Mar 21, 2022 | — |
| SC 14D9 | Schedule 14d9 | Feb 4, 2022 | — |
| SC TO-T | Schedule to | Jan 21, 2022 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 4, 2022 | Dec 1, 2021 |
| 8-K |
Current report
Other events
|
Apr 21, 2021 | Apr 20, 2021 |
| SC 13G | Ownership over 5% (passive) | Oct 9, 2020 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 6, 2020 | Oct 5, 2020 |
| 8-K |
Current report
Other events
|
Apr 13, 2020 | Apr 3, 2020 |
| 8-K |
Current report
Other events
|
Mar 30, 2020 | Mar 30, 2020 |
| 10-Q | Quarterly report | Jan 31, 2020 | Sep 30, 2019 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Dec 12, 2019 | Dec 6, 2019 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Nov 20, 2019 | Nov 15, 2019 |
| NT 10-Q | Form nt 10-q | Nov 13, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Aug 19, 2019 | Jun 30, 2019 |
| NT 10-Q | Form nt 10-q | Aug 14, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Material agreement
|
Aug 9, 2019 | Aug 6, 2019 |
| 8-K |
Current report
Material agreement
|
Jun 13, 2019 | Jun 11, 2019 |
| 10-Q | Quarterly report | May 20, 2019 | Mar 31, 2019 |
| NT 10-Q | Form nt 10-q | May 15, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Material agreement
|
May 7, 2019 | May 3, 2019 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2019 | Apr 17, 2019 |
| 10-K | Annual report | Apr 16, 2019 | Dec 31, 2018 |
| NT 10-K | Form nt 10-k | Apr 1, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 22, 2019 | Mar 19, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 15, 2019 | Jan 15, 2019 |
| 8-K |
Current report
Officer or director change
|
Jan 3, 2019 | Dec 31, 2018 |
| 4 | Insider transaction | Jan 3, 2019 | Dec 31, 2018 |
| 4 | Insider transaction | Jan 3, 2019 | Jan 1, 2019 |
| 4 | Insider transaction | Jan 3, 2019 | Dec 31, 2018 |
| 4 | Insider transaction | Jan 3, 2019 | Dec 31, 2018 |
| 4 | Insider transaction | Jan 3, 2019 | Dec 31, 2018 |
| 4 | Insider transaction | Jan 3, 2019 | Dec 31, 2018 |
| 10-Q | Quarterly report | Nov 16, 2018 | Sep 30, 2018 |
| NT 10-Q | Form nt 10-q | Nov 14, 2018 | Sep 30, 2018 |
| 8-K |
Current report
Material agreement
|
Oct 26, 2018 | Oct 24, 2018 |
| 8-K |
Current report
Material agreement
|
Oct 2, 2018 | Sep 28, 2018 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Sep 21, 2018 | Sep 17, 2018 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Sep 5, 2018 | Sep 4, 2018 |
| DEF 14A | Proxy statement | Aug 28, 2018 | Sep 28, 2018 |
| PRE 14A | Preliminary proxy statement | Aug 15, 2018 | Aug 15, 2018 |
| 10-Q | Quarterly report | Aug 13, 2018 | Jun 30, 2018 |
| 4 | Insider transaction | Aug 13, 2018 | Aug 9, 2018 |
| 4 | Insider transaction | Aug 13, 2018 | Aug 9, 2018 |
| 4 | Insider transaction | Aug 13, 2018 | Aug 9, 2018 |
| 4 | Insider transaction | Aug 13, 2018 | Aug 9, 2018 |
| 4 | Insider transaction | Aug 13, 2018 | Aug 9, 2018 |
| 4 | Insider transaction | Aug 13, 2018 | Aug 9, 2018 |
| 8-K |
Current report
Auditor change, Officer or director change
|
Aug 10, 2018 | Aug 9, 2018 |
| 8-K |
Current report
Officer or director change
|
Jun 28, 2018 | Jun 25, 2018 |
| D | Filing | Jun 12, 2018 | — |
| 8-K |
Current report
Material agreement
|
May 30, 2018 | May 28, 2018 |
| 10-Q | Quarterly report | May 14, 2018 | Mar 31, 2018 |
| 10-K | Annual report | Apr 16, 2018 | Dec 31, 2017 |
| 8-K |
Current report
Other events
|
Apr 4, 2018 | Mar 29, 2018 |
| NT 10-K | Form nt 10-k | Apr 2, 2018 | Dec 31, 2017 |
| 8-K |
Current report
Officer or director change, Other events
|
Jan 19, 2018 | Jan 12, 2018 |
| PRE 14A | Preliminary proxy statement | Dec 13, 2017 | Dec 12, 2017 |
| 10-Q | Quarterly report | Nov 13, 2017 | Sep 30, 2017 |
| 8-K |
Current report
Auditor change
|
Sep 28, 2017 | Sep 27, 2017 |
| SC 13D/A | Amended ownership over 5% (active) | Sep 21, 2017 | — |
| 4 | Insider transaction | Sep 21, 2017 | Sep 11, 2017 |
| 8-K |
Current report
Unregistered share sale, Other events
|
Sep 14, 2017 | Sep 11, 2017 |
| SC 13D | Ownership over 5% (active) | Aug 21, 2017 | — |
| SC 13D/A | Amended ownership over 5% (active) | Aug 18, 2017 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- AURX (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Houston, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1091596
- Former names
- Nuo Therapeutics, Inc (until Dec 23, 2014); CYTOMEDIX INC (until Oct 8, 2014); AUTOLOGOUS WOUND THERAPY INC (until Apr 10, 2000); AUTOLOGOUS WOUND TRERAPY INC (until Mar 23, 2000)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.